Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Surgical,
Oncological and Oral Sciences,
Section of Medical Oncology,
Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology
Marta Castiglia has not added Biography.
If you are Marta Castiglia and would like to personalize this page please email our Author Liaison for assistance.
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions.
Breast cancer research and treatment Aug, 2013 | Pubmed ID: 23925655
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects.
Critical reviews in oncology/hematology Feb, 2014 | Pubmed ID: 24041630
Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines.
BioMed research international , 2013 | Pubmed ID: 24171172
Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?
Expert review of anticancer therapy Oct, 2014 | Pubmed ID: 25148289
Liquid biopsies in lung cancer: the new ambrosia of researchers.
Biochimica et biophysica acta Dec, 2014 | Pubmed ID: 25444714
Cancer and the microbiome: potential applications as new tumor biomarker.
Expert review of anticancer therapy Mar, 2015 | Pubmed ID: 25495037
Improvement in lung cancer outcomes with targeted therapies: an update for family physicians.
Journal of the American Board of Family Medicine : JABFM Jan-Feb, 2015 | Pubmed ID: 25567833
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it.
Translational lung cancer research Aug, 2014 | Pubmed ID: 25806308
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?
Oncotarget Sep, 2015 | Pubmed ID: 26318427
Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls?
Expert opinion on biological therapy , 2015 | Pubmed ID: 26360115
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?
Analytical cellular pathology (Amsterdam) , 2015 | Pubmed ID: 26484003
A headlight on liquid biopsies: a challenging tool for breast cancer management.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Apr, 2016 | Pubmed ID: 26790442
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice.
Oncotarget Feb, 2016 | Pubmed ID: 26919248
Dietary restriction: could it be considered as speed bump on tumor progression road?
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Jun, 2016 | Pubmed ID: 27043958
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?
Oncotarget Apr, 2016 | Pubmed ID: 27081088
University of Palermo
Marco Giallombardo*,1,2,
Jorge Chacártegui Borrás*,2,3,
Marta Castiglia4,
Nele Van Der Steen3,
Inge Mertens5,6,
Patrick Pauwels7,3,
Marc Peeters8,3,
Christian Rolfo2,3
1Department of Biopathology and Medical Biotechnology, Section of Biology and Genetics, University of Palermo,
2Phase I-Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital (UZA),
3Center for Oncological Research (CORE), Antwerp University,
4Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo,
5, Flemish Institute for Technological Research (VITO),
6CORE, Campus Groenenborger, Antwerp University,
7Molecular Pathology, Pathology Department, Antwerp University Hospital (UZA),
8Oncology Department, Antwerp University Hospital (UZA)
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved